Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance and pharmacokinetics study of radioactively labeled BAY 3283142 in healthy men
NL-OMON58713Phase 1Completed
- Sponsor
- Bayer
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BAY3283142, sponsored by Bayer. Primary endpoint: Primary endpoint(s) not publicly disclosed. Started Oct 2024; status: completed.
02
Drugs
BAY3283142
Beyond the preview
Go deeper on NL-OMON58713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58713.